LUCD
Lucid Diagnostics Inc
NASDAQ: LUCD · HEALTHCARE · MEDICAL DEVICES
$1.07
+3.88% today
Updated 2026-04-30
Market cap
$199.66M
P/E ratio
—
P/S ratio
42.43x
EPS (TTM)
$-0.69
Dividend yield
—
52W range
$1 – $2
Volume
0.8M
Lucid Diagnostics Inc (LUCD) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
-7.1%
Last 4 quarters
Revenue YoY growth
+25.6%
Most recent quarter
EPS YoY growth
+47.4%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+0.4%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+2.7%
2026-03-30
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-30 | $-0.10 | -2.6% | $1.12 | $1.15 | +2.7% |
| 2025-11-17 | $-0.10 | +6.3% | $1.07 | $1.05 | -1.9% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.10 | $-0.10 | -2.6% | $1.50M | +25.6% |
| 2025-09-30 | $-0.11 | $-0.10 | +6.3% | $1.21M | +3.3% |
| 2025-06-30 | $-0.11 | $-0.10 | +9.1% | $1.16M | +19.2% |
| 2025-03-31 | $-0.11 | $-0.16 | -41.2% | $828000.00 | -17.3% |
| 2024-12-31 | $-0.17 | $-0.19 | -11.8% | $1.20M | +15.1% |
| 2024-09-30 | $-0.22 | $-0.20 | +9.1% | $1.17M | +49.7% |
| 2024-06-30 | $-0.22 | $-0.23 | -4.5% | $976000.00 | +513.8% |
| 2024-03-31 | $-0.27 | $-0.40 | -48.1% | $1.00M | +124.4% |
| 2023-12-31 | $-0.26 | $-0.25 | +3.8% | $1.04M | — |
| 2023-09-30 | $-0.27 | $-0.34 | -25.9% | $783000.00 | — |
| 2023-06-30 | $-0.32 | $-0.23 | +28.1% | $159000.00 | — |
| 2023-03-31 | $-0.35 | $-0.40 | -14.3% | $446000.00 | — |
| 2022-12-31 | $-0.38 | $-0.23 | +39.5% | — | — |
Frequently asked questions
Has Lucid Diagnostics Inc beaten earnings estimates?
Lucid Diagnostics Inc has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of -7.1% over the last 4 quarters.
How does LUCD stock react to earnings?
LUCD stock has moved an average of +0.4% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Lucid Diagnostics Inc's revenue growth rate?
Lucid Diagnostics Inc reported year-over-year revenue growth of +25.6% in its most recent quarter, with EPS growing +47.4% year-over-year.